Ad is loading...
PROF
Price
$7.52
Change
-$0.17 (-2.21%)
Updated
Nov 21 closing price
109 days until earnings call
RDNT
Price
$81.30
Change
-$0.86 (-1.05%)
Updated
Nov 21 closing price
102 days until earnings call
Ad is loading...

PROF vs RDNT

Header iconPROF vs RDNT Comparison
Open Charts PROF vs RDNTBanner chart's image
Profound Medical
Price$7.52
Change-$0.17 (-2.21%)
Volume$23.15K
CapitalizationN/A
RadNet
Price$81.30
Change-$0.86 (-1.05%)
Volume$315.56K
CapitalizationN/A
PROF vs RDNT Comparison Chart
Loading...
PROF
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
RDNT
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
PROF vs. RDNT commentary
Nov 22, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PROF is a Hold and RDNT is a Buy.

COMPARISON
Comparison
Nov 22, 2024
Stock price -- (PROF: $7.52 vs. RDNT: $81.30)
Brand notoriety: PROF and RDNT are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: PROF: 46% vs. RDNT: 55%
Market capitalization -- PROF: $205.33M vs. RDNT: $3.55B
PROF [@Medical Specialties] is valued at $205.33M. RDNT’s [@Medical Specialties] market capitalization is $3.55B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.03B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PROF’s FA Score shows that 0 FA rating(s) are green whileRDNT’s FA Score has 1 green FA rating(s).

  • PROF’s FA Score: 0 green, 5 red.
  • RDNT’s FA Score: 1 green, 4 red.
According to our system of comparison, RDNT is a better buy in the long-term than PROF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PROF’s TA Score shows that 3 TA indicator(s) are bullish while RDNT’s TA Score has 6 bullish TA indicator(s).

  • PROF’s TA Score: 3 bullish, 7 bearish.
  • RDNT’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, RDNT is a better buy in the short-term than PROF.

Price Growth

PROF (@Medical Specialties) experienced а -6.13% price change this week, while RDNT (@Medical Specialties) price change was +0.30% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +3.22%. For the same industry, the average monthly price growth was +0.99%, and the average quarterly price growth was -2.23%.

Reported Earning Dates

PROF is expected to report earnings on Mar 11, 2025.

RDNT is expected to report earnings on Mar 04, 2025.

Industries' Descriptions

@Medical Specialties (+3.22% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RDNT($3.55B) has a higher market cap than PROF($205M). RDNT YTD gains are higher at: 133.822 vs. PROF (-11.425). RDNT has higher annual earnings (EBITDA): 293M vs. PROF (-26.78M). RDNT has more cash in the bank: 343M vs. PROF (26.2M). PROF has less debt than RDNT: PROF (7.94M) vs RDNT (1.49B). RDNT has higher revenues than PROF: RDNT (1.62B) vs PROF (7.2M).
PROFRDNTPROF / RDNT
Capitalization205M3.55B6%
EBITDA-26.78M293M-9%
Gain YTD-11.425133.822-9%
P/E RatioN/A962.00-
Revenue7.2M1.62B0%
Total Cash26.2M343M8%
Total Debt7.94M1.49B1%
FUNDAMENTALS RATINGS
PROF vs RDNT: Fundamental Ratings
PROF
RDNT
OUTLOOK RATING
1..100
7088
VALUATION
overvalued / fair valued / undervalued
1..100
50
Fair valued
93
Overvalued
PROFIT vs RISK RATING
1..100
1008
SMR RATING
1..100
9889
PRICE GROWTH RATING
1..100
6136
P/E GROWTH RATING
1..100
10078
SEASONALITY SCORE
1..100
8550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PROF's Valuation (50) in the null industry is somewhat better than the same rating for RDNT (93) in the Medical Or Nursing Services industry. This means that PROF’s stock grew somewhat faster than RDNT’s over the last 12 months.

RDNT's Profit vs Risk Rating (8) in the Medical Or Nursing Services industry is significantly better than the same rating for PROF (100) in the null industry. This means that RDNT’s stock grew significantly faster than PROF’s over the last 12 months.

RDNT's SMR Rating (89) in the Medical Or Nursing Services industry is in the same range as PROF (98) in the null industry. This means that RDNT’s stock grew similarly to PROF’s over the last 12 months.

RDNT's Price Growth Rating (36) in the Medical Or Nursing Services industry is in the same range as PROF (61) in the null industry. This means that RDNT’s stock grew similarly to PROF’s over the last 12 months.

RDNT's P/E Growth Rating (78) in the Medical Or Nursing Services industry is in the same range as PROF (100) in the null industry. This means that RDNT’s stock grew similarly to PROF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
PROFRDNT
RSI
ODDS (%)
Bearish Trend 2 days ago
77%
Bearish Trend 2 days ago
71%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
76%
Bearish Trend 2 days ago
69%
Momentum
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
80%
MACD
ODDS (%)
Bearish Trend 2 days ago
76%
Bullish Trend 2 days ago
77%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
82%
Bullish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
82%
Advances
ODDS (%)
Bullish Trend 16 days ago
78%
Bullish Trend 3 days ago
79%
Declines
ODDS (%)
Bearish Trend 2 days ago
79%
Bearish Trend 5 days ago
70%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
70%
Aroon
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
86%
View a ticker or compare two or three
Ad is loading...
PROF
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
RDNT
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ZVNIX39.970.60
+1.52%
Zevenbergen Growth Institutional
JMCEX66.430.94
+1.44%
JPMorgan Mid Cap Equity R2
BDAUX28.480.14
+0.49%
Baron Durable Advantage R6
BMCRX27.57N/A
N/A
BlackRock Advantage Large Cap Gr R
EMOLX16.04-0.05
-0.31%
Lord Abbett Emerging Markets Equity F3

PROF and

Correlation & Price change

A.I.dvisor tells us that PROF and ALC have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PROF and ALC's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PROF
1D Price
Change %
PROF100%
-2.21%
ALC - PROF
30%
Poorly correlated
+0.08%
LZAGY - PROF
29%
Poorly correlated
+0.12%
GH - PROF
27%
Poorly correlated
+0.98%
VCYT - PROF
24%
Poorly correlated
-0.66%
RDNT - PROF
24%
Poorly correlated
-1.05%
More

RDNT and

Correlation & Price change

A.I.dvisor indicates that over the last year, RDNT has been loosely correlated with BLFS. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if RDNT jumps, then BLFS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RDNT
1D Price
Change %
RDNT100%
-1.05%
BLFS - RDNT
48%
Loosely correlated
+1.52%
AZTA - RDNT
47%
Loosely correlated
+1.97%
NTRA - RDNT
43%
Loosely correlated
+0.88%
NVRO - RDNT
39%
Loosely correlated
+3.07%
VCYT - RDNT
39%
Loosely correlated
-0.66%
More